Panagora Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Panagora Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-104,524	Closed	-$4.05M	–	2524
2015 Q1	$4.05M	Hold	104,524	–	–	0.02%	566
2014 Q4	$3.52M	Hold	104,524	–	–	0.02%	563
2014 Q3	$3.66M	Sell	104,524 -116,717	-53%	-$4M	0.02%	575
2014 Q2	$7.27M	Sell	221,241 -4,155	-2%	-$142K	0.04%	425
2014 Q1	$8.31M	Sell	225,396 -18,823	-8%	-$691K	0.04%	407
2013 Q4	$9.37M	Buy	244,219 +54,846	+29%	+$1.73M	0.04%	384
2013 Q3	$5.19M	Buy	+189,373	New	+$4.49M	0.03%	503

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Panagora Asset Management's WX Position: Q2 2015 in Review

Panagora Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 104,524 shares — an estimated $4.05M sold.

Panagora Asset Management first reported a position in WX in Q3 2013 and held it in 7 quarters. The position peaked at $9.37M in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Panagora Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Panagora Asset Management sold 104,524 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $4.05M.
Panagora Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 7 quarters.
Panagora Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.37M in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.